Kang-ai Injection (康艾注射液) Inhibits Gastric Cancer Cells Proliferation through IL-6/STAT3 Pathway
Back to article page
|Updated:2021-09-24
|
Kang-ai Injection (康艾注射液) Inhibits Gastric Cancer Cells Proliferation through IL-6/STAT3 Pathway
Chinese Journal of Integrative MedicinePages: 1-7
Affiliations:
Author bio:
Funds:
Conflict of Interest,The authors declare no financial or commercial conflict of interest.,Supported by National Science and Technology Major Project of the Ministry of Science and Technology of China (No. 2017ZX09304025), Construction Program of Clinical Cooperation Ability of Chinese and Western Medicine for Major and Difficult Diseases (No. 2019-163), the Key Research and Development Program of Liaoning Province (No. 2018225060), Science and Technology Plan Project of Liaoning Province (No. 2016007010), and Science and Technology Plan Project of Shenyang City (No. 19-112-4-099)
DOI:
CLC:
Scan for full text
Chun-lei Zheng, Ke-zuo Hou, An-qi Wang, et al. Kang-ai Injection (康艾注射液) Inhibits Gastric Cancer Cells Proliferation through IL-6/STAT3 Pathway. [J/OL]. 1-7(0)
DOI:
Chun-lei Zheng, Ke-zuo Hou, An-qi Wang, et al. Kang-ai Injection (康艾注射液) Inhibits Gastric Cancer Cells Proliferation through IL-6/STAT3 Pathway. [J/OL]. 1-7(0)DOI:
Kang-ai Injection (康艾注射液) Inhibits Gastric Cancer Cells Proliferation through IL-6/STAT3 Pathway